A Story of Disharmony
October 19, 2017
Researchers find significant variation in regulation of pharmaceutical market systems in the developing world
1 min read
False
Welcome to the October issue. Upfront investigates a new nasal delivery method and how Brexit will impact pharma intellectual property in the UK. Victoria Samanidou asks if age is related to research productivity in “In My View.” Our feature examines globalization and the trend towards international harmonization of pharma regulations. In Next Gen, we explore the untapped potential of plants for drug discovery and manufacturing; and in Best Practice, Jonathan Royce discusses the importance of protein A for the pharma industry. We also Sit Down With Cornell Stamoran, Vice President of Corporate Strategy at Catalent.
October 19, 2017
Researchers find significant variation in regulation of pharmaceutical market systems in the developing world
1 min read
October 16, 2017
Margaret Hamburg served as FDA Commissioner from May 2009 to April 2015, and led the agency through a period of increasing globalization.
1 min read
October 16, 2017
Can microparticles make it possible to administer multiple drugs and vaccines in a single injection?
1 min read
October 16, 2017
Variability in raw materials can cause product quality issues and lead to regulatory problems. Increasingly, our industry requires specific reassurance on elemental impurities, so how can media suppliers provide confidence in this difficult area?Variability in raw materials can cause product quality issues and lead to regulatory problems. Increasingly, our industry requires specific reassurance on elemental impurities, so how can media suppliers provide confidence in this difficult area?
1 min read
October 16, 2017
The era of cell therapies is upon the industry. To ensure that processes run smoothly, safely, and cost effectively, we must embrace a more automated approach.
1 min read
October 16, 2017
Respiratory drug development lags behind other therapeutic areas, but why? And what new advances could help shape the future?
1 min read
October 16, 2017
How much untapped potential do plants have for both discovering and manufacturing drugs?
1 min read
October 16, 2017
Where would the biopharma industry be without Protein A? And can it ever be topped?
1 min read
October 13, 2017
With globalization creating opportunities for companies but causing havoc for regulators, an industrywide demand for regulatory harmony has arisen. But who benefits? And how will the picture look in the years to come? We survey pharma’s global regulatory landscape.
1 min read
October 13, 2017
Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.
1 min read
October 13, 2017
What does your product demand guesstimate look like? Blue skies ahead? Heavy thunderstorms? More importantly, how can you be sure that the winds won’t suddenly change?
1 min read
October 13, 2017
The nose is not just an anatomical region for locally-acting drugs – it is an open door offering rapid access to different organs
1 min read
October 13, 2017
Age-based stereotypes exist, even in scientific communities. But is age related to research productivity – and, if so, to what extent?
1 min read
October 13, 2017
Record generic approvals, a joint opioid investigation, and emerging technology guidance... What’s new for pharma in business?
1 min read
October 13, 2017
Could donated skin be a viable alternative to animal testing?
1 min read
October 13, 2017
An exhibition in London explores the relationship between graphic design and health
1 min read
October 13, 2017
Nominations close on November 10 for The Medicine Maker 2017 Innovation Awards
1 min read
October 13, 2017
Could a new nasal delivery method finally get drugs to the central nervous system?
1 min read
October 13, 2017
The future status of pharma intellectual property in the UK depends on the outcome of Brexit
1 min read
October 13, 2017
Despite the fantastic technologies at the industry’s disposal and increasing efforts to round up counterfeit criminals, fake medicines still find their way into supply chains.
1 min read
False
False
False